Oncology drug lag in Japan: has it improved over the last decade?

ConclusionsDrug lag has not decreased over the last decade. The percentage of pivotal trials for US approval that included Japan has increased but should be further increased in the future. Japan may require a scheme to encourage smaller non-Japanese companies to include Japan in their global clinical development plan.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research